Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G G Enas

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|August 28, 2001
Enhancing the value delivered by the statistician throughout drug discovery and development: putting statistical science into regulated pharmaceutical innovationG G Enas, J S Andersen
Statistics in Medicine|September 28, 1998
A framework establishing clear decision criteria for the assessment of drug efficacyW J Huster, G G Enas
Statistics in Medicine|May 15, 1995
Defining, monitoring and combining safety information in clinical trialsG G Enas, D J Goldstein
Statistics in Medicine|March 1, 1993
Data monitoring and interim analyses in the pharmaceutical industry: ethical and logistical considerationsF W Rockhold, G G Enas
Journal of Biopharmaceutical Statistics|March 1, 1993
A simple stopping rule for declaring treatment ineffectiveness in clinical trialsG G Enas, W W Offen
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 1, 1994
Pattern analysis method for assessing successful weight reductionS L Holman, D J Goldstein, G G Enas
Neurosurgery|June 1, 1983
Effects of therapeutic pentobarbital coma on multimodality evoked potentials recorded from severely head-injured patientsP G Newlon, R P Greenberg, G G Enas, et al.
Clinical Pharmacology and Therapeutics|June 1, 1985
Effect of fluoxetine on psychomotor performance, physiologic response, and kinetics of ethanolL Lemberger, H Rowe, R F Bergstrom, et al.
Controlled Clinical Trials|March 1, 1989
Monitoring versus interim analysis of clinical trials: a perspective from the pharmaceutical industryG G Enas, B E Dornseif, C B Sampson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1985
Clinical pharmacology of tomoxetine, a potential antidepressantR L Zerbe, H Rowe, G G Enas, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|August 28, 2001
Enhancing the value delivered by the statistician throughout drug discovery and development: putting statistical science into regulated pharmaceutical innovationG G Enas, J S Andersen
Statistics in Medicine|September 28, 1998
A framework establishing clear decision criteria for the assessment of drug efficacyW J Huster, G G Enas
Statistics in Medicine|May 15, 1995
Defining, monitoring and combining safety information in clinical trialsG G Enas, D J Goldstein
Statistics in Medicine|March 1, 1993
Data monitoring and interim analyses in the pharmaceutical industry: ethical and logistical considerationsF W Rockhold, G G Enas
Journal of Biopharmaceutical Statistics|March 1, 1993
A simple stopping rule for declaring treatment ineffectiveness in clinical trialsG G Enas, W W Offen
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 1, 1994
Pattern analysis method for assessing successful weight reductionS L Holman, D J Goldstein, G G Enas
Neurosurgery|June 1, 1983
Effects of therapeutic pentobarbital coma on multimodality evoked potentials recorded from severely head-injured patientsP G Newlon, R P Greenberg, G G Enas, et al.
Clinical Pharmacology and Therapeutics|June 1, 1985
Effect of fluoxetine on psychomotor performance, physiologic response, and kinetics of ethanolL Lemberger, H Rowe, R F Bergstrom, et al.
Controlled Clinical Trials|March 1, 1989
Monitoring versus interim analysis of clinical trials: a perspective from the pharmaceutical industryG G Enas, B E Dornseif, C B Sampson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1985
Clinical pharmacology of tomoxetine, a potential antidepressantR L Zerbe, H Rowe, G G Enas, et al.
Pageof 2